For research teamsHelp me find a study
Back to all studies
RecruitingEUCTR 2021-005078-25

Phase III randomized, multicenter open label study to evaluate the efficacy of immunomodulatory therapy in case of psychiatric disorders with proven dysimmunity.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Mental health, Mental and behavioral disorders (F00-F99), ...Biological
In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
CHU de Bordeaux
Sponsor type
Hospital / academic medical center
Study type
Biological
Intervention type
BIOLOGICAL
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France
Age range
Not clearly listed
Official registry ID
EUCTR 2021-005078-25
Official title
Phase III randomized, multicenter open label study to evaluate the efficacy of immunomodulatory therapy in case of psychiatric disorders with proven dysimmunity.

Want help reviewing this study?

Loading the security check...
Study ID: EUCTR 2021-005078-25. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

View the historical EU CTR record (opens in a new tab)View the current CTIS record (opens in a new tab)
Current CTIS country statuses
Historical EU CTR country statuses
  • France : Trial now transitioned

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 9 sites
  • Centre Hospitalier Henri Mondor — Psychiatrie et Addictologie
    Aurillac Cedex
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Charles Perrens — Psychiatrie adulte
    Bordeaux
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Universitaire De Bordeaux — Neuropédiatrie
    Bordeaux
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Le Vinatier — Psychiatrie adulte
    Bron
    Site status: Not listed — confirm with the team
  • University Hospital Of Clermont-Ferrand — Psychiatrie adulte
    Clermont Ferrand Cedex 1
    Site status: Not listed — confirm with the team
  • Assistance Publique Hopitaux De Paris — Psychiatrie et Addictologie
    Colombes Cedex
    Site status: Not listed — confirm with the team
  • Bicetre Hospital — Neuropédiatrie
    Le Kremlin Bicetre Cedex
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Universitaire De Montpellier — Psychiatrie adulte
    Montpellier Cedex 5
    Site status: Not listed — confirm with the team
  • Les Hopitaux Universitaires De Strasbourg — Psychiatrie
    Strasbourg Cedex
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.